PTGX Q1 2026 Earnings Surprise Profitability Defies Estimates Amid No Revenue INTS Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Clinical Pipeline SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development ORGN Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Operational Hurdles SMFG Q1 2026 Earnings Earnings Miss Drags Shares Despite Stable Core Operations CGEN Q1 2026 Earnings EPS Misses Estimates but Stock Rises 728 on Pipeline Progress